CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Viatar CTC Solutions Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Viatar CTC Solutions Inc
116 John St Ste 10
Phone: (617) 299-6590p:617 299-6590 LOWELL, MA  01852-1124  United States Ticker: VRTTVRTT

This company ceased filing statements with the SEC on 12/27/2016.

Business Summary
Viatar CTC Solutions Inc., formerly Vizio Medical Devices LLC, is a medical technology company. The Company is focused on developing and marketing products to collect cancer cells for molecular diagnostics by others and as cancer therapy, both of which are based on the principle of removing blood-borne circulating tumor cells (CTCs). These CTCs detach from solid tumors and enter the bloodstream carrying the deoxyribonucleic acid (DNA) of the tumor and seeding new tumors. The Company is seeking to commercialize over two products, which utilizes its CTC removal technology, including Viatar Collection System for Molecular Analysis, which collects and purifies a quantity of CTCs from approximately 50 milliliters of blood as the front end for DNA sequencing and other genetic analysis technologies used primarily for research, and Viatar Therapeutic Oncopheresis System, which removes CTCs from a patient's blood as a cancer therapy for metastatic disease.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
-Yes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201612/31/2015YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer, Chief Financial Officer IlanReich 60 1/1/2008 1/1/2008
Vice President - Research & Development StephenKeaney 54 1/1/2012 1/1/2012
Director DavidBoral 33 5/23/2016 5/23/2016
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Viatar LLC
VRTT

General Information
Number of Employees: 8 (As of 3/30/2015)
Outstanding Shares: 19,495,426 (As of 11/14/2016)
Stock Exchange: OTC
Federal Tax Id: 261581305
Fax Number: (302) 674-5266


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, August 08, 2019